Viewing nowCombinationLinaglipitin/Metformin HCl Tablets 2.5/500 mg
Linagliptin 2.5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Hallym Pharmaceutical Co., Ltd.

MFDS item code 201902779 · Approved 2019.04.30 · Insurance code 645306140
Improvement of glycemic control in patients with type 2 diabetes mellitus
This medication is used to improve blood sugar control in patients with type 2 diabetes in conjunction with diet and exercise. The combination of linaglipitin and metformin effectively aids in blood sugar management.
The dose of this medicine should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended doses of each component: linagliptin 2.5 mg and metformin 1000 mg twice daily. This medicine should be administered twice daily with meals. To reduce gastrointestinal adverse reactions associated with metformin use, the dose should be increased gradually. 1. Patients not currently receiving metformin: For patients with no prior history of antidiabetic drug therapy who do not achieve adequate glycemic control with monotherapy, the initial dose is 1 tablet of this medicine 2.5/500 mg twice daily. The dose may be increased to 1 tablet of this medicine 2.5/1000 mg twice daily. 2. Switching from combination therapy with linagliptin and metformin: Patients switching from combination therapy with linagliptin and metformin to this medicine should start at the same doses of linagliptin and metformin that they were previously taking. 3. Patients with inadequate glycemic control on combination therapy with insulin and metformin: The initial dose of this medicine should be considered to provide linagliptin 2.5 mg twice daily (total daily dose 5 mg) and a dose similar to the patient's current metformin dose. When this medicine is coadministered with insulin, a reduction in the insulin dose may be necessary to reduce the risk of hypoglycemia (see Precautions for Use, 3. Patients Requiring Caution). No studies have been conducted to evaluate the safety and efficacy of switching to this medicine in patients previously treated with another oral antihyperglycemic agent. Any change in the treatment regimen for type 2 diabetes may cause changes in glycemic control; therefore, caution should be exercised and appropriate monitoring should be performed. Patients with renal impairment This medicine may be used in patients with moderate renal impairment stage 3a (creatinine clearance [CrCl] 45≤~<60 ml/min or estimated glomerular filtration rate (eGFR) 45≤~<60 mL/min/1.73 m2) who do not have other conditions that may increase the risk of lactic acidosis, provided the following dose adjustment is made. Because the starting dose of metformin is 500mg or 850mg once daily, treatment should not be initiated with this medicine. The maximum recommended dose of metformin is 500 mg twice daily. Renal function should be carefully monitored every 3-6 months. If renal function declines to CrCl < 45 ml/min or eGFR < 45 ml/min/1.73m2, this medicine should be discontinued immediately. Patients with hepatic impairment This medicine should not be administered to patients with hepatic impairment due to its metformin component (see Precautions for Use, 2. Patients in Whom This Medicine Is Contraindicated).
This medication may cause a rare but serious side effect known as lactic acidosis; therefore, it should not be used in patients with impaired kidney function or severe cardiac disease. Patients who are allergic to any ingredients in this medication or those with type 1 diabetes, diabetic ketoacidosis, or diabetic coma should not take it. Patients with decreased kidney function, acute infections, dehydration, severe trauma, heart failure, liver dysfunction, or alcohol abuse should be very cautious when taking this medication. Pregnant or nursing women are advised to avoid this medication, and those who plan to become pregnant should consult a doctor. Symptoms of hypoglycemia may occur during treatment with this medication; therefore, it is essential to closely monitor blood sugar changes, especially when taken with insulin or sulfonylurea medications. Additionally, since this medication is primarily excreted through the kidneys, regular kidney function tests should be performed, and if kidney function worsens, the doctor should be notified immediately. When undergoing a radiologic examination that utilizes iodinated contrast agents, this medication should be discontinued for a period before and after the examination, and it should also be stopped for a period prior to any surgical procedures. Acute pancreatitis or skin blistering disorders may occur, so if severe abdominal pain or unusual skin symptoms arise, immediate consultation with healthcare personnel is necessary. Due to the metformin component, there may be a risk of vitamin B12 deficiency; therefore, checking blood vitamin B12 levels is necessary during long-term use. This medication may interact with other drugs, so it is essential to inform the doctor or pharmacist about any other medications being taken. Safety and efficacy in children and adolescents have not been established, so it is not recommended for this age group. Elderly patients are at higher risk of kidney function decline, so kidney function should be frequently monitored, and appropriate dose adjustments are necessary while taking this medication. Patients should be cautious when driving or operating machinery while taking this medication, and in case of an overdose, they should seek appropriate medical treatment immediately. Store the medication in a place protected from moisture and out of reach of children, and it is advisable not to transfer it to another container.
Lactic acidosis, nasopharyngitis, hypersensitivity, angioedema, urticaria, decreased and deficiency of vitamin B12, hypoglycemia, taste disturbance, cough, decreased appetite, diarrhea, constipation, nausea, pancreatitis, vomiting, abdominal pain, oral ulcer formation, abnormal liver function tests, hepatitis, pruritus, erythema, rash, bullous pemphigoid, severe and disabling arthralgia, rhabdomyolysis, increased lipase, increased amylase, upper abdominal pain, enterocolitis, intestinal obstruction, gastritis, herpes zoster, cystitis, acute pyelonephritis, bronchitis, vestibular neuronitis, sepsis, pneumonia, gastrointestinal disorders, constipation, upper abdominal pain, dyspepsia, stomatitis, cerebral infarction, speech disorder, Alzheimer's dementia, chest pain, fever, facial swelling, fatigue, chronic obstructive pulmonary disease, asthma, dermatological lesions, acute leukemia, basal cell carcinoma, non-small cell lung cancer, malignant pericardial effusion, gastric cancer, rectal cancer, pancreatic cancer, meniscus injury, pneumoconiosis, congestive heart failure, angina, acute myocardial infarction, unstable angina, cardiac arrest, diabetic retinopathy, acute kidney injury, end-stage renal disease, acute cholangitis, acute cholecystitis, cholangitis, dizziness, kidney transplant failure, anxiety, mood disorder, insomnia, depression, contusion, bone contusion, concussion, bone fracture, hand fracture, itching, hypertension, erectile dysfunction, goiter, anemia, dizziness, drowsiness, chest discomfort, asthenia, pain, nosebleed, oropharyngeal pain, vocal disorders, epistaxis, hearing loss, benign prostatic hyperplasia, benign, malignant, and unspecified neoplasms (including cysts and polyps), confusion state, nocturia, dermatitis, hypercholesterolemia, dyslipidemia, decreased hemoglobin, increased blood potassium, increased blood creatinine, increased blood creatine phosphokinase, increased ALT, increased AST, increased blood triglycerides, increased blood creatinine, increased blood glucose, inadequate blood sugar control, malnutrition, hyponatremia, dehydration, drowsiness, headache, sensory disturbances, postherpetic neuralgia, partial paralysis, syncope, subdural effusion, osteoarthritis, limb pain, musculoskeletal discomfort, myositis, myalgia, soft tissue mass, postmenopausal osteoporosis, rotator cuff syndrome, male pattern baldness, hyperhidrosis, dermatitis, anxiety, insomnia, depression, angina, acute myocardial infarction, unstable angina, palpitations, diabetic neuropathy, diabetic foot, diabetic neuropathy, inadequate diabetes control, elevated blood pressure, decreased blood pressure, flushing, fever, facial swelling, hyperthermia, back pain, flank pain, myelodysplastic syndrome, papilloma, thyroid nodule, vitreous hemorrhage, confusion state, nocturia, dermatitis
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to air and moisture, so it must be stored in a tightly closed container. It is important to maintain a storage temperature between 1 to 30 degrees Celsius.
Bright yellow, biconvex, round film-coated tablets
30 tablets/bottle, 60 tablets/bottle, 100 tablets/bottle, 200 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationLinagliptin 2.5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Hallym Pharmaceutical Co., Ltd.
CombinationLinagliptin 2.5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationLinagliptin 2.5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationLinagliptin 2.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
Linagliptin 2.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Anguk Pharm Co., Ltd.
Linagliptin 2.5mg · Metformin Hydrochloride 1000mg
Prescription medication · Combination
Hanmi Pharmaceutical Co., Ltd.
CombinationLinagliptin 2.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Kukje Pharmaceutical Co., Ltd.
CombinationLinagliptin 2.5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
International Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.